Zymedyne is pleased to announce that it has successfully filed a new patent application on Tetrahydroquinoline compounds that cover complete Composition of matter and “Use Of”. This application is expected to be WIPO registered in 2025-2026.
Zymedyne registers new provisional patent application
Previous article$300K Alberta Innovates AICE Grant securedNext article Further $100k UCEED investment secured